(Q37820673)

23 August 2017

1 reference

title

Novel glucokinase activators: a patent review (2008 - 2010). (English)

1 reference

23 August 2017

Ramakanth Sarabu

1

1 reference

23 August 2017

Steven J Berthel

series ordinal

2

1 reference

23 August 2017

Robert F Kester

series ordinal

3

1 reference

23 August 2017

Jefferson W Tilley

series ordinal

4

1 reference

23 August 2017

language of work or name

English

0 references

publication date

15 December 2010

1 reference

Expert Opinion on Therapeutic Patents

23 August 2017

published in

1 reference

23 August 2017

volume

21

1 reference

23 August 2017

issue

1

1 reference

23 August 2017

page(s)

13-33

1 reference

Allosteric activators of glucokinase: potential role in diabetes therapy

23 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.542413

Assessing the potential of glucokinase activators in diabetes therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.542413

Pyridones as glucokinase activators: identification of a unique metabolic liability of the 4-sulfonyl-2-pyridone heterocycle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.542413

2,3-Disubstituted acrylamides as potent glucokinase activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.542413

Glucokinase activators: Novo Nordisk's WO2008084044 and Array Biopharma's WO2008091770.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F13543776.2011.542413

10.1517/13543776.2011.542413

21 January 2018

Identifiers

DOI

1 reference

23 August 2017

1 reference